DC cell culture strategy

DC cell culture strategy

Liquid error (snippets/article-card line 119): The format option '%d %b, %Y' is not a supported format.AntBio

Overview In 1973, Steinmen and Cohn of Rockeller University in the United States first discovered a cell with many dendritic protrusions on the surface from the isolation of mouse splenocytes,...

07 Aug 2025AntBio

DC cell culture strategy

Overview In 1973, Steinmen and Cohn of Rockeller University in the United States first discovered a cell with many dendritic protrusions on the surface from the isolation of mouse splenocytes,...

Read More
The Rising Star in Tumor Targets - Claudin18.2 Antibody Now Available

The Rising Star in Tumor Targets - Claudin18.2 Antibody Now Available

Liquid error (snippets/article-card line 119): The format option '%d %b, %Y' is not a supported format.AntBio

Introduction Gastric cancer ranks as the third leading cause of cancer-related mortality globally, characterized by robust metastatic potential. Common metastatic sites include the peritoneum, lymph nodes, liver, lungs, and bone....

06 Aug 2025AntBio

The Rising Star in Tumor Targets - Claudin18.2 Antibody Now Available

Introduction Gastric cancer ranks as the third leading cause of cancer-related mortality globally, characterized by robust metastatic potential. Common metastatic sites include the peritoneum, lymph nodes, liver, lungs, and bone....

Read More
Immunohistochemical (IHC) Tumor Markers | Common Breast Cancer Diagnostics

Immunohistochemical (IHC) Tumor Markers | Common Breast Cancer Diagnostics

Liquid error (snippets/article-card line 119): The format option '%d %b, %Y' is not a supported format.AntBio

Breast cancer, a common type of malignant tumor, poses a significant threat to women's health. However, with the continuous advancement of medical technology, we now have more precise and effective...

06 Aug 2025AntBio

Immunohistochemical (IHC) Tumor Markers | Common Breast Cancer Diagnostics

Breast cancer, a common type of malignant tumor, poses a significant threat to women's health. However, with the continuous advancement of medical technology, we now have more precise and effective...

Read More
CDx Antibodies | Emerging Targets B7-H3/H4, Facilitating ADC Drug Development

CDx Antibodies | Emerging Targets B7-H3/H4, Facilitating ADC Drug Development

Liquid error (snippets/article-card line 119): The format option '%d %b, %Y' is not a supported format.AntBio

B7-H3 B7-H3 (also known as CD276) is a type I transmembrane protein and a newly identified member of the B7 family of immune regulatory proteins. It has emerged as a...

06 Aug 2025AntBio

CDx Antibodies | Emerging Targets B7-H3/H4, Facilitating ADC Drug Development

B7-H3 B7-H3 (also known as CD276) is a type I transmembrane protein and a newly identified member of the B7 family of immune regulatory proteins. It has emerged as a...

Read More
A New Boost for Immunohistochemistry: The Launch of Recombinant Rabbit Monoclonal Antibodies Against Helicobacter pylori (Hp)!

A New Boost for Immunohistochemistry: The Launch of Recombinant Rabbit Monocl...

Liquid error (snippets/article-card line 119): The format option '%d %b, %Y' is not a supported format.AntBio

What is Helicobacter pylori? Helicobacter pylori (Hp) is a Gram-negative, microaerophilic, and slow-growing bacterium. Its helical shape has evolved to penetrate the gastric mucus layer, thereby causing infection. Once Hp...

06 Aug 2025AntBio

A New Boost for Immunohistochemistry: The Launch of Recombinant Rabbit Monocl...

What is Helicobacter pylori? Helicobacter pylori (Hp) is a Gram-negative, microaerophilic, and slow-growing bacterium. Its helical shape has evolved to penetrate the gastric mucus layer, thereby causing infection. Once Hp...

Read More
The PD-L1 IHC antibody has been officially launched on the market!

The PD-L1 IHC antibody has been officially launched on the market!

Liquid error (snippets/article-card line 119): The format option '%d %b, %Y' is not a supported format.AntBio

Introduction to PD-1/PD-L1The mechanism of action of PD-1/PD-L1 inhibitors involves blocking the interaction between PD-L1 expressed on tumor cells and PD-1 receptors on T cells. Tumor cells exhibit surface expression...

06 Aug 2025AntBio

The PD-L1 IHC antibody has been officially launched on the market!

Introduction to PD-1/PD-L1The mechanism of action of PD-1/PD-L1 inhibitors involves blocking the interaction between PD-L1 expressed on tumor cells and PD-1 receptors on T cells. Tumor cells exhibit surface expression...

Read More